Endothelial cell infection and dysfunction, immune activation in severe COVID-19
Zhongnan Qin,Fengming Liu,Robert Blair,Chenxiao Wang,Haoran Yang,Joseph Mudd,Joshua M Currey,Naoki Iwanaga,Jibao He,Ren Mi,Kun Han,Cecily C. Midkiff,Mohammad Afaque Alam,Bertal H Aktas,Richard S Vander Heide,Ronald Veazey,Giovanni Piedimonte,Nicholas J Maness,Süleyman Ergün,Franck Mauvais-Jarvis,Jay Rappaport,Jay K. Kolls,Xuebin Qin
DOI: https://doi.org/10.7150/thno.61810
IF: 11.6
2021-01-01
Theranostics
Abstract:<b>Rationale</b>: Pulmonary vascular endotheliitis, perivascular inflammation, and immune activation are observed in COVID-19 patients. While the initial SARS-CoV-2 infection mainly infects lung epithelial cells, whether it also infects endothelial cells (ECs) and to what extent SARS-CoV-2-mediated pulmonary vascular endotheliitis is associated with immune activation remain to be determined. <b>Methods</b>: To address these questions, we studied SARS-CoV-2-infected <i>K18-hACE2</i> (<i>K18</i>) mice, a severe COVID-19 mouse model, as well as lung samples from SARS-CoV-2-infected nonhuman primates (NHP) and patient deceased from COVID-19. We used immunostaining, RNAscope, and electron microscopy to analyze the organs collected from animals and patient. We conducted bulk and single cell (sc) RNA-seq analyses, and cytokine profiling of lungs or serum of the severe COVID-19 mice. <b>Results</b>: We show that SARS-CoV-2-infected <i>K18</i> mice develop severe COVID-19, including progressive body weight loss and fatality at 7 days, severe lung interstitial inflammation, edema, hemorrhage, perivascular inflammation, systemic lymphocytopenia, and eosinopenia. Body weight loss in <i>K18</i> mice correlated with the severity of pneumonia, but not with brain infection. We also observed endothelial activation and dysfunction in pulmonary vessels evidenced by the up-regulation of VCAM1 and ICAM1 and the downregulation of VE-cadherin. We detected SARS-CoV-2 in capillary ECs, activation and adhesion of platelets and immune cells to the vascular wall of the alveolar septa, and increased complement deposition in the lungs, in both COVID-19-murine and NHP models. We also revealed that pathways of coagulation, complement, K-ras signaling, and genes of ICAM1 and VCAM1 related to EC dysfunction and injury were upregulated, and were associated with massive immune activation in the lung and circulation. <b>Conclusion</b>: Together, our results indicate that SARS-CoV-2 causes endotheliitis via both infection and infection-mediated immune activation, which may contribute to the pathogenesis of severe COVID-19 disease.
medicine, research & experimental